当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析 - 现金流量表

益丰药房

(603939)

  

流通市值:339.29亿  总市值:339.36亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金6,655,595,055.9725,476,899,360.2318,703,468,518.2312,655,238,785.35
收到其他与经营活动有关的现金44,426,798.87288,148,116.91148,283,132.52119,465,201.57
经营活动现金流入的平衡项目0000
经营活动现金流入小计6,700,021,854.8425,765,047,477.1418,851,751,650.7512,774,703,986.92
购买商品、接受劳务支付的现金3,662,301,479.4614,557,574,284.2510,309,537,960.417,486,914,918.08
支付给职工以及为职工支付的现金1,198,067,921.613,939,587,865.713,134,581,574.532,133,535,171.81
支付的各项税费306,906,979.331,327,948,156.211,083,282,952.29696,908,525.56
支付其他与经营活动有关的现金418,359,782.861,718,670,086.44982,574,785.33635,647,054.15
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,585,636,163.2621,543,780,392.6115,509,977,272.5610,953,005,669.6
经营活动产生的现金流量净额平衡项目00-0.010.01
经营活动产生的现金流量净额1,114,385,691.584,221,267,084.533,341,774,378.181,821,698,317.33
二、投资活动产生的现金流量:
收回投资收到的现金-7,104,317.53--
取得投资收益收到的现金-17,084,00017,084,00017,084,000
处置固定资产、无形资产和其他长期资产收回的现金净额1,026,497.4966,273,150.18614,204.36199,130.04
收到的其他与投资活动有关的现金6,050,272,846.1816,015,012,371.9212,401,641,806.796,804,198,838.29
投资活动现金流入的平衡项目0000
投资活动现金流入小计6,051,299,343.6716,105,473,839.6312,419,340,011.156,821,481,968.33
购建固定资产、无形资产和其他长期资产支付的现金53,604,459.82682,673,370.81319,849,827.25209,449,093.92
取得子公司及其他营业单位支付的现金64,847,698.15254,664,562.64215,727,858.13185,134,960
支付其他与投资活动有关的现金6,126,500,00018,776,985,007.4815,554,160,0008,281,406,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计6,244,952,157.9719,714,322,940.9316,089,737,685.388,675,990,053.92
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-193,652,814.3-3,608,849,101.3-3,670,397,674.23-1,854,508,085.59
三、筹资活动产生的现金流量:
吸收投资收到的现金-5,938,756.586,431,0005,391,000
其中:子公司吸收少数股东投资收到的现金-5,938,756.586,431,0005,391,000
取得借款收到的现金-30,000,0001,803,932,0001,783,932,000
收到其他与筹资活动有关的现金-1,783,932,000--
筹资活动现金流入平衡项目-000
筹资活动现金流入小计-1,819,870,756.581,810,363,0001,789,323,000
偿还债务支付的现金61,429,093.4175,337,093.470,853,093.49,424,000
分配股利、利润或偿付利息支付的现金4,063,315.98951,468,847.52604,739,986.11321,621,760.12
其中:子公司支付给少数股东的股利、利润3,961,138.92104,925,012.9391,771,002.7712,762,100.63
支付其他与筹资活动有关的现金375,295,058.231,613,265,067.971,225,433,275.83885,908,795.89
筹资活动现金流出平衡项目0000
筹资活动现金流出小计440,787,467.612,740,071,008.891,901,026,355.341,216,954,556.01
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-440,787,467.61-920,200,252.31-90,663,355.34572,368,443.99
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额479,945,409.67-307,782,269.08-419,286,651.39539,558,675.73
加:期初现金及现金等价物余额2,160,797,870.522,468,580,139.62,468,580,139.62,468,580,139.6
期末现金及现金等价物余额平衡项目000.010
期末现金及现金等价物余额2,640,743,280.192,160,797,870.522,049,293,488.223,008,138,815.33
补充资料:
净利润-1,652,782,285.86-860,070,534.32
资产减值准备-102,396,476.85-38,797,603.61
固定资产和投资性房地产折旧-239,555,369.91-103,073,391.98
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-239,555,369.91-103,073,391.98
无形资产摊销-32,025,308.07-15,933,484.08
长期待摊费用摊销-264,925,013.28-121,411,946.26
处置固定资产、无形资产和其他长期资产的损失--49,938,810.67--14,952,132.95
固定资产报废损失-3,836,499.95-1,113,651.47
财务费用-174,148,877.4-102,736,750.31
投资损失--108,128,784.49--49,447,044.49
递延所得税--12,515,021.8--58,039,020.28
其中:递延所得税资产减少-5,971,649.51--48,888,593.89
递延所得税负债增加--18,486,671.31--9,150,426.39
存货的减少--790,972,542.4-28,131,737.19
经营性应收项目的减少--554,453,059.73-214,579,437.96
经营性应付项目的增加-1,593,308,427.28--330,520,077.03
其他-65,423,461.4-10,651,295.16
现金的期末余额-2,160,797,870.52-3,008,138,815.33
减:现金的期初余额-2,468,580,139.6-2,468,580,139.6
公告日期2025-04-292025-04-292024-10-312024-08-30
审计意见(境内)标准无保留意见
TOP↑